AsiaPhos anticipates rebound in Q2 2024

The company reported a net loss of $0.38m in H1 2023.

AsiaPhos Limited anticipates its Q1 and H1 2024 net earnings to improve on a year-on-year basis, compared to the net loss recorded in the same quarter in 2023.

The rebound is influenced by “fair value gain on other equity investment," AsiaPhos said in an SGX filing.

It is also partly thanks to gains on transfer of foreign currency translation reserve upon the deconsolidation of its foreign subsidiary, Sichuan Rongdafeng Chemical Co. (Rongdafeng), following the handover of Rongdafeng's control to Sichuan Rongda Yuexiang Chemical Group Co. (Rongda) related to the disposal of the P4 Plant.

In the same half last year, the SGX-listed group narrowed its net loss to $0.38m.

Full details regarding its Q2 profits will be disclosed on or before 14 August.

Follow the link for more news on

SGX

stock exchange

The people you want to reach are already in this room.

Every quarter, SBR lands on the desks of the founders, CFOs, and directors running Asia's most consequential companies. Every day, they open our newsletter and read our website. It's a room that took twenty years to build — and it's the one most of our partners are trying to get into.

The good news is that the door is open. We work with companies on thought leadership articles, sponsored content, industry summits across Southeast Asia, regional awards programmes, podcasts, and media placements in print and digital. The shape of the right partnership depends on what you're trying to do, which is why we'd rather start with a conversation than send a rate card.

If you have something this room should know about, tell us. We'll tell you honestly whether we can help, and how.

No rate cards until we understand the brief. It's a better use of everyone's time.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia